Health & Biotech
Health & Biotech
Happy animal, happy human: Cannabis products for pets proving a financial hit for Creso
Health & Biotech
ResApp won’t be diagnosing croup with its coughing smartphone app
Health & Biotech
GI Dynamics just took another step forward on its path to treat obesity and diabetes
Health & Biotech
Stem cell biotech companies welcome $150 million in decade-long funding
Health & Biotech
US can’t resist Recce’s new antibiotic: A patent’s in the bag and human trials are afoot
Health & Biotech
Really good boys are experts at taking PharmAust’s cancer drug
Health & Biotech
MGC Pharma adds expertise to its board as it progresses toward becoming a major cannabis biopharma
Health & Biotech
Going to the pot: Affinity still suspended as it tries to scrape together some cash
Health & Biotech
Sigma puts the kibosh on Priceline owner API’s merger offer, API is furious
Health & Biotech
The Pot Seat: Medlab’s Sean Hall on why marijuana is a better bet than hemp
Health & Biotech
Pot stock Zelda is coming to America – someday – after signing a pharma deal
Health & Biotech
Medical cannabis play Bod lands its first deal to sell its health products overseas
Health & Biotech
‘Mice are a failed experiment’: Why you shouldn’t get revved up about pre-clinical trials
Health & Biotech
Dr Boreham’s Crucible: Trial results could be the US leg-up Volpara’s looking for
Health & Biotech
1st Group’s EyeHealth1st to stage early intervention for eye disease in Aussies over 40 and drive advertising revenue
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.